Female infertility associated with anovulation. Female infertility associated with anovulation
Conditions
Interventions
Intervention 1: Control group: A dose of 150 mcg corrifolitropin alfa received on the third day of the menstrual cycle , Antagonist drug Orgalutran, 5 mg is given on the seventh day.
Then, during th
Treatment - Drugs
Control group: A dose of 150 mcg corrifolitropin alfa received on the third day of the menstrual cycle , Antagonist drug Orgalutran, 5 mg is given on the seventh day.
Then, during the monitoring cy
Intervention group: A dose of 150 mcg corrifolitropin alfa is administrated on the third day of the menstrual cycle. Antagonist drug Orgalutran, 5 mg is given on the seventh day.
Then on the sevent
Sponsors
vhice chancellor of
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria:All patients agreed upon ESHRE Criteria 2011 ,advanced maternal age( >40 years )? previous poor ovarian respond (POR)? abnormal ovarian reserve Test ( AFC=5-7, AMH=0.5-1.1)are enrolled. Exclusion Criteria:Cigaret user; history of ovarian cyst or surjeri in ovary;primary sensitivity to Cinal Or Gonal-F ; Tumors depended to Sex in reproductive systhem ;Adrenal failure or oncontrlod Thyroid;andometriosis;couple chromosomal difficulties;ovulatory dysfunction ( hypogonadic or hypergonadic infertility , hyperprolactinemia,thyroid disease, neoplastic ovary and adrenal,Kushing syndrome).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mature oocyte. Timepoint: time of getting oocyte. Method of measurement: microscopic assay.;Number of fetus. Timepoint: two days after getting of oocytes. Method of measurement: microscopic assay by embryologists. | — |
Secondary
| Measure | Time frame |
|---|---|
| Days of ovulation induction. Timepoint: Medication at the time of ovulation induction. Method of measurement: Patient records.;Abortion. Timepoint: two weeks after embryo transfer. Method of measurement: transvaginal sonography and blood test.;Pregnancy. Timepoint: two weeks after embryo transfer. Method of measurement: transvaginal sonography and blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr,Batoolashidi
Vali-e-Asr reproductive HealthnResearch center
Outcome results
None listed